NCT00005996 2013-12-19
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
Clinical Trials
10 trialsNCT00026377 2013-09-05
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
University of Chicago
Phase 1 Completed
NCT00006000 2013-01-31
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003720 2012-08-23
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Pfizer
Phase 1 Completed
NCT00005642 2010-06-11
SU5416 in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00005822 2010-06-11
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00005647 2010-06-10
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00006257 2010-01-13
SU5416 and Paclitaxel in Treating Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00006247 2009-10-14
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Pediatric Brain Tumor Consortium
Phase 1 Terminated
NCT00006155 2008-03-04
SU5416 and Carboplatin to Treat Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed